Published in Exp Dermatol on March 01, 2005
Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest (2006) 1.90
Effects of virtual reality immersion and audiovisual distraction techniques for patients with pruritus. Pain Res Manag (2009) 0.96
Effects of butorphanol on morphine-induced itch and analgesia in primates. Anesthesiology (2007) 0.94
The association between anxiety sensitivity and atopy in adult asthmatics. J Behav Med (2008) 0.88
Tonic inhibition of TRPV3 by Mg2+ in mouse epidermal keratinocytes. J Invest Dermatol (2012) 0.81
Spinal Functions of B-Type Natriuretic Peptide, Gastrin-Releasing Peptide, and Their Cognate Receptors for Regulating Itch in Mice. J Pharmacol Exp Ther (2015) 0.79
Nalfurafine, the kappa opioid agonist, inhibits icilin-induced wet-dog shakes in rats and antagonizes glutamate release in the dorsal striatum. Neuropharmacology (2006) 0.78
Association of skin with the pathogenesis and treatment of neurodegenerative amyloidosis. Front Neurol (2012) 0.76
Icilin-evoked behavioral stimulation is attenuated by alpha₂-adrenoceptor activation. Brain Res (2011) 0.75
Efficacy of Acupuncture in Itch: A Systematic Review and Meta-Analysis of Clinical Randomized Controlled Trials. Evid Based Complement Alternat Med (2015) 0.75
How to treat that nasty itch. Exp Dermatol (2005) 0.75
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy (2009) 4.10
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy (2009) 3.86
CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate. Cell (1992) 3.70
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol (1998) 3.54
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10
A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol (1999) 2.92
Identification of desmoglein, a constitutive desmosomal glycoprotein, as a member of the cadherin family of cell adhesion molecules. Eur J Cell Biol (1990) 2.77
Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles. Antimicrob Agents Chemother (1979) 2.53
Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation (1991) 2.28
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Home versus hospital deliveries: follow up study of matched pairs for procedures and outcome. Zurich Study Team. BMJ (1996) 2.10
Three metronidazole-resistant strains of Trichomonas vaginalis from the United States. Am J Obstet Gynecol (1980) 2.06
Novel classes of responsive and unresponsive C nociceptors in human skin. J Neurosci (1995) 1.97
Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J (2006) 1.92
Efficacy of capsaicin in the treatment of acne in one case: new pathophysiological perspectives. J Eur Acad Dermatol Venereol (2009) 1.90
The important role of neuropeptides in complex regional pain syndrome. Neurology (2001) 1.88
Mast cells as sentinels of innate immunity. Curr Opin Immunol (1999) 1.85
Painful stimuli evoke different stimulus-response functions in the amygdala, prefrontal, insula and somatosensory cortex: a single-trial fMRI study. Brain (2002) 1.84
Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy (2006) 1.84
Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature (1997) 1.78
Frequency of aquagenic palmoplantar keratoderma in cystic fibrosis: a new sign of cystic fibrosis? Br J Dermatol (2010) 1.77
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J (2001) 1.74
Wood-burning stoves and lower respiratory illnesses in Navajo children. Pediatr Infect Dis J (1996) 1.73
Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Agents Chemother (1987) 1.72
Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis (2001) 1.72
Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine (Phila Pa 1976) (2001) 1.68
Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. Br J Dermatol (2000) 1.66
EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy (2009) 1.65
Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology (2006) 1.65
The pruritus of cholestasis. Hepatology (1999) 1.63
Surface charge and hemolytic activity of asbestos. Environ Res (1977) 1.62
Functional attributes discriminating mechano-insensitive and mechano-responsive C nociceptors in human skin. J Neurosci (1999) 1.61
Nerve fibre discharges, cerebral potentials and sensations induced by CO2 laser stimulation. Hum Neurobiol (1984) 1.60
Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest (1999) 1.59
PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium. Clin Exp Allergy (2007) 1.59
In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer. Prostate (2001) 1.58
Endocytosis of junctional cadherins in bovine kidney epithelial (MDBK) cells cultured in low Ca2+ ion medium. J Cell Biol (1991) 1.57
Molecular cloning, chromosome mapping and characterization of UBQLN3 a testis-specific gene that contains an ubiquitin-like domain. Gene (2000) 1.57
How to assess disease activity in patients with chronic urticaria? Allergy (2008) 1.55
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy (2006) 1.55
Surface charge and asbestos toxicity. Nature (1977) 1.53
Embolization of biologic glue during repair of aortic dissection. Ann Thorac Surg (1995) 1.52
Fractures of the base of the middle phalanx of the finger. Classification, management and long-term results. J Bone Joint Surg Br (1997) 1.52
Cutaneous manifestations of primary Sjögren's syndrome are underestimated. Clin Exp Rheumatol (2004) 1.50
Use of an X-ray television for diffraction of the frog striated muscle. Nature (1975) 1.50
Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J (2000) 1.48
IgG4-related skin disease. Br J Dermatol (2014) 1.48
Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain (2000) 1.45
Skin innervation at different depths correlates with small fibre function but not with pain in neuropathic pain patients. Eur J Pain (2012) 1.45
Facilitated neurogenic inflammation in complex regional pain syndrome. Pain (2001) 1.43
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci U S A (2001) 1.43
Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy (2010) 1.42
Methotrexate therapy of primary biliary cirrhosis: promising but worrisome. Gastroenterology (1991) 1.41
Fatal recurrent subarachnoid hemorrhage after complete endovascular aneurysm occlusion. AJNR Am J Neuroradiol (2006) 1.40
Subcortical structures involved in pain processing: evidence from single-trial fMRI. Pain (2002) 1.40
Determination of sulfobromophthalein excretion in rabbits. Am J Physiol (1988) 1.39
Acute postnatal increase of extracellular antioxidant defence of neonates: the role of iron metabolism. Acta Paediatr (2001) 1.39
The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy (2009) 1.39
Responses of human cutaneous afferents to CO2 laser stimuli causing pain. Exp Brain Res (1984) 1.38
Pleiotropic effects of Pasteurella multocida toxin are mediated by Gq-dependent and -independent mechanisms. involvement of Gq but not G11. J Biol Chem (2000) 1.38
A new non-syndromic type of familial carcinomas? J Eur Acad Dermatol Venereol (2008) 1.38
Injection pain of rocuronium and vecuronium is evoked by direct activation of nociceptive nerve endings. Eur J Anaesthesiol (2003) 1.37
Assay conditions and the demonstration of nitroimidazole resistance in Tritrichomonas foetus. Antimicrob Agents Chemother (1978) 1.35
Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy (2013) 1.35
Painful stimuli evoke itch in patients with chronic pruritus: central sensitization for itch. Neurology (2004) 1.34
A constitutive transmembrane glycoprotein of Mr 165,000 (desmoglein) in epidermal and non-epidermal desmosomes. I. Biochemical identification of the polypeptide. Eur J Cell Biol (1986) 1.33
NMR solution structure of a complex of calmodulin with a binding peptide of the Ca2+ pump. Biochemistry (1999) 1.33
Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev (1998) 1.31
High prevalence of silent celiac disease in preschool children screened with IgA/IgG antiendomysium antibodies. J Pediatr Gastroenterol Nutr (1999) 1.30
A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology (1992) 1.30
Topography and nociceptive receptive fields of climbing fibres projecting to the cerebellar anterior lobe in the cat. J Physiol (1991) 1.29
p53 is essential for chemotherapy-induced hair loss. Cancer Res (2000) 1.29
Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol (2001) 1.29
Pyrrolidine inhibitors of human cytosolic phospholipase A(2). J Med Chem (2000) 1.28
Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol (2008) 1.28
EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy (2006) 1.28
Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol (1994) 1.27
Cross-resistance of Trichomonads to 5-nitroimidazole-derivatives. Experientia (1976) 1.27
Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 1.26
A simultaneous (15)N, (1)H- and (13)C, (1)H-HSQC with sensitivity enhancement and a heteronuclear gradient echo. J Biomol NMR (1995) 1.25
Isolation of Trichomonas vaginalis resistant to metronidazole. Lancet (1978) 1.25
Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J Immunol (1998) 1.25
Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol (2006) 1.24
Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways. Am J Respir Crit Care Med (2000) 1.24
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol (2013) 1.22
Imipramine reduces experimental pain. Pain (1986) 1.22
Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma. Am J Clin Oncol (2001) 1.22
Time course of post-excitatory effects separates afferent human C fibre classes. J Physiol (2000) 1.22
Characterization of functional vanilloid receptors expressed by mast cells. Blood (1998) 1.21
Adverse health effects of selenium in humans. Rev Environ Health (2002) 1.21
[Cross-sectional field 14 pain medicine. Implementation of the German Pain Society (DGSS) core curriculum in the model study course MaReCuM]. Schmerz (2013) 1.21
Activity of terbinafine in experimental fungal infections of laboratory animals. Antimicrob Agents Chemother (1987) 1.20
Late somatosensory evoked cerebral potentials in response to cutaneous heat stimuli. Electroencephalogr Clin Neurophysiol (1988) 1.20
p53 Involvement in the control of murine hair follicle regression. Am J Pathol (2001) 1.19